Dr. Martha Boeckenfeld Shares VetiGel Creation Experiment: How A 17-Year-Old Mixed Algae in a Small Hidden Lab
Dr. Martha Boeckenfeld, CEO and Founder of the Marthaverse, posted on LinkedIn:
“A 17-year-old mixed algae in a small lab hidden on his grandfather’s Hudson Valley vineyard.
It grabbed wet tissue and wouldn’t let go.
That experiment turned into VetiGel: a plant-based gel that seals wounds and helps blood clot.
Trauma care’s hard problem:
Severe bleeding is the leading cause of preventable trauma death.
A major arterial bleed can kill in 3–5 minutes.
Most products need firm pressure, the right wound shape, and time.
Deep, jagged wounds are tough to pack.
What Joe built:
- A gel that seals fast and triggers clotting
- No manual pressure
- Stops bleeding in under 20 seconds
Works on skin and organs
The proof: In veterinary surgery on 16 dogs, VetiGel cut blood loss from 78 mL to 6.7 mL. Time to hemostasis dropped from 25 minutes to under 2.
Cresilon later created TraumaGel for humans. It’s FDA cleared.
It made Time’s “Best Inventions of 2025.”
The Department of Defense signed on.
Picture an earthquake. A mother pinned under rubble, bleeding from a deep wound. No ambulance for 40 minutes. A responder applies gel. The bleeding stops.
She’s still alive when rescue arrives.
We spent decades accepting some bleeds are too fast and too deep to stop in time. A kid in a vineyard lab didn’t accept that.
Follow me, Dr. Martha Boeckenfeld, for stories where curiosity changes medicine.
Share if you think big medical advances can start everywhere. We just need imagination!
This is my find for YOU on the the last Day of 2025 to show, how human imagination is saving lives!”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
-
May 23, 2026, 16:38José Octavio Alva Bucio: Securing the Future of Plasma and Blood-Derived Medicines
-
May 23, 2026, 16:33Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH
-
May 23, 2026, 16:24Marc Wittwer: A Practical Viscoelastic-Guided Algorithm for Trauma-Induced Coagulopathy in Clinical Workflow